The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $81.28

Today's change-0.89 -1.08%
Updated March 31 4:05 PM EDT. Delayed by at least 15 minutes.
 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $81.28

Today's change-0.89 -1.08%
Updated March 31 4:05 PM EDT. Delayed by at least 15 minutes.

DaVita HealthCare Partners Inc down (U.S.)$0.89

DaVita HealthCare Partners Inc closed lower Tuesday, dropping (U.S.)$0.89 or 1.08% to (U.S.)$81.28. Shares have lost 1.11% over the last five days, but sit 2.12% below their 52-week high. This security has outperformed the S&P 500 by 7.61% during the last year.

Key company metrics

  • Open(U.S.) $81.76
  • Previous close(U.S.) $82.17
  • High(U.S.) $82.00
  • Low(U.S.) $81.23
  • Bid / Ask(U.S.) $80.74 / (U.S.) $84.78
  • YTD % change+7.31%
  • Volume809,017
  • Average volume (10-day)1,129,789
  • Average volume (1-month)1,446,388
  • Average volume (3-month)1,276,264
  • 52-week range(U.S.) $66.60 to (U.S.) $83.04
  • Beta0.62
  • Trailing P/E24.39×
  • P/E 1 year forward21.88×
  • Forward PEG5.20×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.33
Updated March 31 4:05 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.75%

Based on its net profit margin of 6.75%, DaVita HealthCare Partners Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue3,3283,2523,1723,043
Total other revenue--------
Total revenue3,3283,2523,1723,043
Gross profit962925926863
Total cost of revenue2,3662,3272,2472,180
Total operating expense2,8762,8142,6882,602
Selling / general / administrative361327302287
Research & development--------
Depreciation / amortization153149146143
Interest expense (income), net operating--------
Unusual expense (income)01700
Other operating expenses, total--------
Operating income452438484441
Interest income (expense), net non-operating-131-98-195-106
Gain (loss) on sale of assets--------
Other--------
Income before tax354336282337
Income after tax250220181212
Income tax, total104117101125
Net income208184148183
Total adjustments to net income--00--
Net income before extra. items208184148183
Minority interest-42-36-34-28
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items208184148183
Inc. avail. to common incl. extra. items208184148183
Diluted net income208184148183
Dilution adjustment0----0
Diluted weighted average shares218217217216
Diluted EPS excluding extraordinary itemsvalue per share0.960.850.680.85
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.960.900.680.85